{"id":1696,"date":"2018-10-31T14:45:05","date_gmt":"2018-10-31T14:45:05","guid":{"rendered":"http:\/\/bibliography.nanobiotix.com\/2018-astro-nbtxr3-in-solid-tumors\/"},"modified":"2022-05-24T16:41:50","modified_gmt":"2022-05-24T15:41:50","slug":"2018-astro-nbtxr3-in-solid-tumors","status":"publish","type":"post","link":"https:\/\/bibliography.nanobiotix.com\/fr\/2018-astro-nbtxr3-in-solid-tumors\/","title":{"rendered":"2018 \u2013 ASTRO \u2013 NBTXR3 in solid tumors"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row padding_top=\u00a0\u00bb0&Prime; padding_bottom=\u00a0\u00bb0&Prime; section_container_layout=\u00a0\u00bbfull-width\u00a0\u00bb remove_horizontal_padding=\u00a0\u00bbyes\u00a0\u00bb module_type=\u00a0\u00bbbg-color\u00a0\u00bb gutter_size=\u00a0\u00bbyes\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb bg_color=\u00a0\u00bb#28282e\u00a0\u00bb][vc_column][vc_row_inner padding_top=\u00a0\u00bb0&Prime; padding_bottom=\u00a0\u00bb0&Prime; gutter_size=\u00a0\u00bbyes\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb][vc_column_inner column_paddings=\u00a0\u00bb105&Prime; column_position_vertical=\u00a0\u00bbmiddle\u00a0\u00bb column_min_height=\u00a0\u00bb700&Prime; column_min_height_sm=\u00a0\u00bb400&Prime; column_min_height_xs=\u00a0\u00bb350&Prime; module_type=\u00a0\u00bbbg-image\u00a0\u00bb bg_image=\u00a0\u00bb99&Prime; mask_fx=\u00a0\u00bbyes-mask\u00a0\u00bb mask_color_mode=\u00a0\u00bbpalette\u00a0\u00bb mask_bg_color_palette=\u00a0\u00bbmain-mask\u00a0\u00bb animation_fx=\u00a0\u00bbyes-animation\u00a0\u00bb animation_delay=\u00a0\u00bb200&Prime; animation_offset_scroll_down=\u00a0\u00bb90&Prime; width=\u00a0\u00bb1\/2&Prime; animation_in=\u00a0\u00bbfadeInUp\u00a0\u00bb][vc_empty_space height=\u00a0\u00bb60px\u00a0\u00bb responsive_lg=\u00a0\u00bbhidden\u00a0\u00bb responsive_md=\u00a0\u00bbhidden\u00a0\u00bb][az_box_icons box_icon_title=\u00a0\u00bbAuthors\u00a0\u00bb box_icon_color_mode=\u00a0\u00bbon-the-fly\u00a0\u00bb icon_visibility=\u00a0\u00bbyes-icon\u00a0\u00bb icon_type=\u00a0\u00bbfont\u00a0\u00bb icon=\u00a0\u00bbfa fa-edit\u00a0\u00bb icon_color_mode=\u00a0\u00bbon-the-fly\u00a0\u00bb icon_size=\u00a0\u00bb50&Prime; box_icon_color=\u00a0\u00bb#ffffff\u00a0\u00bb icon_color=\u00a0\u00bb#ffffff\u00a0\u00bb]Thariat J. O.<span class=\"notes up\">1<\/span>, Le Tourneau C.<span class=\"notes up\">2<\/span>, Chajon Rodriguez E.<span class=\"notes up\">3<\/span>, Sargos P.<span class=\"notes up\">4<\/span>, Le Pechoux C.<span class=\"notes up\">5<\/span>, Kantor G.<span class=\"notes up\">6<\/span>, Hoffmann C.<span class=\"notes up\">7<\/span>, Moreno Garcia V.<span class=\"notes up\">7<\/span>, De Baere T.<span class=\"notes up\">5<\/span>, Vendrely V.<span class=\"notes up\">8<\/span>, Rio E.<span class=\"notes up\">9<\/span>, Lecesne A.<span class=\"notes up\">10<\/span>, Gronchi A.<span class=\"notes up\">11<\/span>, Nguyen P. L.<span class=\"notes up\">12<\/span>, Dicker A. P.<span class=\"notes up\">13<\/span>, Seiwert T. Y.<span class=\"notes up\">14<\/span>, Papai Z.<span class=\"notes up\">15<\/span>, Rutkowski P.<span class=\"notes up\">16<\/span>, Bonvalot S.<span class=\"notes up\">2<\/span><br \/>\n<span class=\"notes\"><br \/>\n1 \u2013 Radiation Oncology, Centre Fran\u00e7ois Baclesse, Caen, France<br \/>\n2 \u2013 Institut Curie, Paris, France<br \/>\n3 \u2013 Centre Eug\u00e8ne Marquis &#8211; D\u00e9partement de Radioth\u00e9rapie, Rennes, France<br \/>\n4 \u2013 Department of Radiation Oncology. Institut Bergonie, Bordeaux, France<br \/>\n5 \u2013 Institut Gustave Roussy, Villejuif, France<br \/>\n6 \u2013 Department of Radiotherapy, Institut Bergoni\u00e9, Bordeaux, France<br \/>\n7 \u2013 START Madrid, Madrid, Spain<br \/>\n8 \u2013 University Hospital of Bordeaux, Bordeaux, France<br \/>\n9 \u2013 Institut de Canc\u00e9rologie de l\u2019Ouest, Nantes, France<br \/>\n10 \u2013 Service d&rsquo;Oncologie m\u00e9dicale Gustave Roussy, Villejuif, France<br \/>\n11 \u2013 Istituto Nazionale Tumori, Milan, Italy<br \/>\n12 \u2013 Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women&rsquo;s Hospital, Harvard Medical School, Boston, MA<br \/>\n13 \u2013 Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA<br \/>\n14 \u2013 University of Chicago, Chicago, IL<br \/>\n15 \u2013 Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary<br \/>\n16 \u2013 Centrum Onkologii-Instytut im. Sklodowskiej-Curie w Warszawie, Warszawa, Poland<br \/>\n<\/span>[\/az_box_icons][vc_empty_space height=\u00a0\u00bb60px\u00a0\u00bb responsive_lg=\u00a0\u00bbhidden\u00a0\u00bb responsive_md=\u00a0\u00bbhidden\u00a0\u00bb][\/vc_column_inner][vc_column_inner column_paddings=\u00a0\u00bb105&Prime; column_position_vertical=\u00a0\u00bbmiddle\u00a0\u00bb module_type=\u00a0\u00bbbg-color\u00a0\u00bb animation_fx=\u00a0\u00bbyes-animation\u00a0\u00bb animation_delay=\u00a0\u00bb300&Prime; animation_offset_scroll_down=\u00a0\u00bb90&Prime; width=\u00a0\u00bb1\/2&Prime; bg_color=\u00a0\u00bb#ffffff\u00a0\u00bb animation_in=\u00a0\u00bbfadeInUp\u00a0\u00bb][vc_empty_space height=\u00a0\u00bb60px\u00a0\u00bb responsive_lg=\u00a0\u00bbhidden\u00a0\u00bb responsive_md=\u00a0\u00bbhidden\u00a0\u00bb][az_box_icons box_icon_title=\u00a0\u00bbSummary\u00a0\u00bb icon_visibility=\u00a0\u00bbyes-icon\u00a0\u00bb icon_type=\u00a0\u00bbfont\u00a0\u00bb icon=\u00a0\u00bbaz-icon az-icon-layers2&Prime; icon_color_mode=\u00a0\u00bbon-the-fly\u00a0\u00bb icon_color=\u00a0\u00bb#28282e\u00a0\u00bb icon_size=\u00a0\u00bb50&Prime;]To improve radiotherapy (RT) in terms of tumor response and to reduce irradiation of healthy tissues, innovative therapeutic approaches are needed. In response, NBTXR3, injectable hafnium oxide nanoparticles, was developed for the treatment of solid tumors.<\/p>\n<p>Once injected intratumorally, NBTXR3 can deposit high energy within tumors only when activated by an ionizing radiation source, like current standard RTs. Upon activation, the high energy radiation physically kills the tumor cells by triggering DNA damage and cell destruction improving clinical outcomes.<\/p>\n<p>Since its first successful clinical evaluation in a completed phase I trial in patients with locally advanced soft tissue sarcoma, NBTXR3 is currently evaluated in numerous indications worldwide (EU, Asia, US).<\/p>\n<p>NBTXR3 have shown promising results in non-clinical studies with marked antitumor efficacy and in clinical development in terms of safety and preliminary evaluations of efficacy. Considering the preliminary results of the 145 patients injected across all clinical trials, these first-in-class nanoparticles have already proven to be an encouraging innovative treatment in various types of tumors. The last patient of the phase II\/III trial in STS was included and the results of this study regarding efficacy and safety will soon be disclosed.[\/az_box_icons][vc_empty_space height=\u00a0\u00bb60px\u00a0\u00bb responsive_lg=\u00a0\u00bbhidden\u00a0\u00bb responsive_md=\u00a0\u00bbhidden\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>To improve radiotherapy (RT) in terms of tumor response and to reduce irradiation of healthy tissues, innovative therapeutic approaches are needed. In response, NBTXR3, injectable hafnium oxide nanoparticles, was developed for the treatment of solid tumors. Once injected intratumorally, NBTXR3 can deposit high energy within tumors only when activated by an ionizing radiation source, like current standard RTs. [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":1676,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[182,183,669,673,674,668],"tags":[196,439,342,200,525,203],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/posts\/1696"}],"collection":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/comments?post=1696"}],"version-history":[{"count":0,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/posts\/1696\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media\/1676"}],"wp:attachment":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media?parent=1696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/categories?post=1696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/tags?post=1696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}